![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 28, 21025-21032, July 14, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Cell Biology Programme, Research Institute, The Hospital
for Sick Children and the Department of Biochemistry, University of
Toronto, Toronto, Ontario M5G 1X8, Canada
Received for publication, March 21, 2000
The factors contributing to the establishment of
the steady state Golgi pH (pHG) were studied in
intact and permeabilized mammalian cells by fluorescence ratio
imaging. Retrograde transport of the nontoxic B subunit of
verotoxin 1 was used to deliver pH-sensitive probes to the Golgi
complex. To evaluate whether counter-ion permeability limited the
activity of the electrogenic V-ATPase, we determined the concentration
of K+ in the lumen of the Golgi using a null point
titration method. The [K+] inside the Golgi was found to
be close to that of the cytosol, and increasing its permeability had no
effect on pHG. Moreover, the capacity of the endogenous
counter-ion permeability exceeded the rate of H+ pumping,
implying that the potential across the Golgi membrane is negligible and
has little influence on pHG. The V-ATPase does not reach
thermodynamic equilibrium nor does it seem to be allosterically inactivated at the steady state pHG. In fact, active
H+ pumping was detectable even below the resting
pHG. A steady state pH was attained when the rate of
pumping was matched by the passive backflux of H+
(equivalents) or "leak." The nature of this leak pathway was investigated in detail. Neither vesicular traffic nor
H+/cation antiporters or symporters were found to
contribute to the net loss of H+ from the Golgi. Instead,
the leak was sensitive to voltage changes and was inhibited by
Zn2+, resembling the H+ conductive pathway of
the plasma membrane. We conclude that a balance between an endogenous
leak, which includes a conductive component, and the H+
pump determines the pH at which the Golgi lumen attains a steady state.
Stringent regulation of the internal pH of endomembrane
compartments is required for their optimal function. In mitochondria, alkalinization of the matrix contributes to the generation of the
transmembrane proton-motive force used to generate ATP (1). By
contrast, luminal acidification is essential for the distribution and
degradation of internalized ligands in the endocytic pathway (2-4),
whereas it regulates post-translational modification and sorting of
proteins along the secretory pathway (5-7). The pH varies in different
subcompartments of the endocytic pathway, with acidification increasing
progressively from the endocytic vesicles and early endosomes to late
endosomes and ultimately lysosomes (8). Conversely, the pH of the
secretory pathway becomes more acidic as the cargo travels toward the
cell surface. Although the pH of the endoplasmic reticulum is thought
to be near neutral (9, 10), acidification develops along the Golgi complex and is maximal at the trans-Golgi network (11-13).
The development of such gradients appears to be important in targeting and retrieving components to and from individual subcompartments (6,
15). However, little is known about the determinants of pH in each
subcompartment and particularly about the source of their differential
acidification. In the case of the secretory pathway, this paucity of
information is attributable, in part, to methodological limitations.
Until very recently, determination of the luminal pH of the endoplasmic
reticulum, Golgi, or trans-Golgi network was limited to the
use of static, immunoelectron microscopy-based methods (16, 17). In the
past couple of years, however, a variety of ingenious techniques have
been introduced that allow the continuous and comparatively noninvasive
detection of pH in intact cells. These include the microinjection of
pH-responsive probes trapped in size-fractionated liposomes (14, 18),
the transfection of pH-sensitive variants of green fluorescent protein linked to organelle-specific targeting sequences (10, 13), and the
expression of targetted chimeric constructs that can be used to trap
soluble probes in specific organelles (12, 19). In addition, bacterial
proteins have been used to measure the pH of the Golgi complex (11).
Toxins produced by Shigella and by enteropathogenic strains
of Escherichia coli have been shown to bind to surface
glycolipids and to be subsequently transported along an endogenous
retrograde pathway, accumulating in the Golgi complex (20, 21). We used
these toxins earlier to estimate the pH of the Golgi in cultured cells
and, in agreement with other recent studies, found this compartment to
be acidic as a result of active proton pumping by a vacuolar-type ATP
hydrolase vacuolar (V-ATPase)1 (11).
The stoichiometry of the V-ATPase is generally believed to be 2-3
protons/ATP hydrolyzed (22). On a thermodynamic basis, a maximum
transmembrane pH gradient of 4.2 units could therefore be generated by
the V-ATPase at 37 °C. Because in most cells the cytosolic pH
approximates 7.2 (23, 24), an intra-Golgi pH of 3 could be reached if
the ATPase attained chemical
equilibrium.2 This value
differs markedly from the reported values, which range between 6.25 and
6.58 (11, 13, 19). The apparent discrepancy could in principle be
attributed to the development of an electrical potential (inside
positive) across the Golgi membrane. An electrical potential would
develop if the rate of proton pumping exceeds the rate of permeation of
counter-ions (see Ref. 25 for model). Alternatively, "leak"
pathways could facilitate the escape of protons from within the
organelle, thereby partially dissipating the gradient generated by the
ATPase. The contribution of these mechanisms to the establishment
of the steady state pH of the Golgi was assessed in the present study,
where we used fluorescence ratio imaging to monitor signals emitted by
recombinant B subunit of verotoxin 1 (VT1B) that was covalently coupled
to a pH-sensitive probe.
Materials and Solutions--
GTP
The calibration KCl-rich solution contained 140 mM KCl, 10 mM glucose, 10 mM HEPES, 10 mM MES,
1 mM CaCl2, and 1 mM
MgCl2, pH 6-7. The permeabilization buffer consisted of 90 mM potassium glutamate, 50 mM KCl, 10 mM NaCl, 1 mM MgCl2, 2 mM CaCl2, 4 mM EGTA, 2 mM K2HPO4, 20 mM HEPES,
4 mM ATP, 3 mM sodium pyruvate, and 1 mM mg/ml bovine serum albumin, pH 7.2. EGTA was omitted in
the experiments where ZnCl2 was used. Where indicated, the concentration of K+ was altered by isoosmolar replacement
with NMG+. EGTA was removed from the permeabilization. In
the experiments where ZnCl2 was used, EGTA was removed from
the permeabilization buffer.
Toxin Purification and Labeling--
VT1B was purified as
described earlier by affinity chromatography (26). Purified VT1B was
fluoresceinated by the addition of FITC directly to VT1B (1:1 (w/w)
ratio) in 0.5 M
Na2CO3/NaHCO3, pH 9.5. The mixture
was gently rotated for 1-2 h at room temperature, after which free
FITC was removed. The resulting labeled toxin is called FITC-VT1B hereafter.
Cell Culture, Labeling, and Permeabilization--
Vero cells
were cultured at 37 °C in minimal essential medium containing
glutamine, vitamins, 5% fetal calf serum, 40 µg/ml gentamicin, and
1% penicillin-streptomycin under 5% CO2. To label the
Golgi, cells were washed three times in cold phosphate-buffered saline
containing 1 mM CaCl2 and 1 mM
MgCl2, pH 7.4, and then preincubated with 10 µg/ml of
FITC-labeled VT1B in phosphate-buffered saline for 1 h at
4 °C to promote binding to the plasmalemmal receptors without
endocytosis. After washing twice with phosphate-buffered saline,
internalization was initiated by incubating the cells at 37 °C for
1 h in minimal essential medium.
Where indicated, cells were permeabilized by incubation for 5 min at
37 °C in permeabilization buffer containing 0.25 µg/ml of SLO. The
effectiveness of the permeabilization protocol was assessed by
incubating the cells for 5 min in the presence of the impermeant dye
FM143 (1 µg/ml) and analyzing its distribution by fluorescence
imaging. The kinetics of equilibration of small solutes in
permeabilized cells were also quantified by fluorescence microscopy.
Following permeabilization, cells were pre-equilibrated with Lucifer
Yellow (1 mM) and then abruptly switched to
permeabilization buffer without dye. The rate of loss of internal
fluorescence was continuously monitored by digital imaging.
Other Methods--
Staining and mounting of samples for
immunofluorescence, acquisition of images, and fluorescence ratio
imaging of intra-Golgi pH were performed as described in Ref. 11.
Quantification of cell-associated fluorescence was performed using
Metamorph/Metafluor software (Universal Imaging, West Chester, PA).
Calibration was performed in situ at the end of each
experiment by sequentially perfusing the cells with KCl-rich medium
(125 mM KCl, 20 mM NaCl, 10 mM
HEPES, 10 mM MES, 0.5 mM CaCl2, and
0.5 mM MgCl2) containing 5 µg/ml of the
K+/H+ ionophore nigericin and buffered to pH
values ranging from 5.5 to 7.5. Data were plotted using the Origin
software (MicroCal Software Inc., Northhampton, MA) and are
representative of at least three separate experiments of each type.
Unless otherwise indicated, experiments were performed at 37 °C.
Golgi pH Measurements Using FITC-VT1B
The fluorescence of FITC-VT1B was used to measure Golgi pH
(pHG). FITC-VT1B (10 µg/ml) was initially bound to the
surface of Vero cells by incubation for 1 h at 4 °C, followed
by washing and incubation for another hour at 37 °C to allow
internalization of the probe. The intracellular localization of
FITC-VT1B was confirmed by fluorescence microscopy. As illustrated in
Fig. 1A, the toxin accumulates
in a compact juxtanuclear compartment reported earlier to coincide with
the Golgi complex (11). Accordingly, the distribution of the toxin
overlaps precisely with that of Fluorescence ratio imaging was used to estimate pHG
in otherwise untreated Vero cells. pHG averaged 6.47 ± 0.4 (means ± S.E.) in four separate experiments and increased
rapidly upon addition of 500 nM concanamycin, an inhibitor
of the V-ATPase, approaching the cytosolic pH within 5-10 min (see below).
Estimation of Intra-Golgi [K+]
Calibration of pHG using nigericin rests on the
assumption that the luminal Golgi [K+] is comparable with
that of the cytosol. To our knowledge, however, the [K+]
of the Golgi complex has not been determined. To validate the calibration method and to define the potential counter-ion composition of the Golgi, we implemented a null point procedure to estimate [K+] (29). The method is based on the mechanism of action
of nigericin, which carries out a one-for-one, electroneutral exchange
of K+ for H+ (30). As a result, the exchange
process will cease when
[K+]i/[K+]o = [H+]i/[H+]o. Because
cytosolic pH is known, the intra-Golgi [K+] can be
estimated by assessing the effect of nigericin on pHG when
the cytosolic compartment is bathed at varying concentrations of
K+.
This experimental paradigm requires manipulation of the
[K+] of the extra-Golgi (cytosolic) compartment. This
could in principle be performed by inhibition of the
Na+/K+-ATPase combined with judicious choice of
the composition of the extracellular medium. However, the resulting
cytosolic [K+] changes would be slow, and parallel
changes in the Golgi [K+] are likely to occur. Ideally,
the change in cytosolic [K+] must be imposed abruptly
prior to addition of nigericin to preclude spurious changes in Golgi
[K+].
Rapid changes in extra-Golgi ionic composition were imposed by
permeabilizing cells with SLO, a bacterial toxin that binds to
cholesterol, generating pores on the plasma membrane without necessarily altering the integrity of intracellular compartments (31).
Effective permeabilization of the plasma membrane by SLO was shown by
labeling the cells with FM143, a membrane impermeant amphiphilic dye
that becomes fluorescent upon insertion in lipid bilayers. As shown in
Fig. 2A, when added to intact
cells the fluorescence of FM143 is restricted to the plasma membrane
and forming endosomes. When added following treatment with SLO, FM143 rapidly stains intracellular membranes with a resulting ~10-fold increase in cell-associated fluorescence (note that a much longer exposure time was used in Fig. 2 for A than for
B). Importantly, no changes in the resting pHG
were detected for up to 10 min in cells treated with SLO (Figs.
3 and 6 and Table
I), confirming that this organelle
remains intact after selective permeabilization of the plasma
membrane.
Determinants of the pH of the Golgi Complex*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
S,
,
'-dipyridyl, TPEN,
and valinomycin were from Sigma. Nigericin was from Molecular Probes,
Inc. (Eugene, OR), and concanamycin A was from Kamiya Biochemical
Company (Thousand Oaks, CA). The polyclonal antibody to
-mannosidase
II was the kind gift of Dr. M. Farquhar (University of California, San
Diego, CA). Cy3-labeled donkey anti-rabbit antibodies were from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA). Lyophilized streptolysin O (SLO) was provided by Dr. S. Bhakdi (Johannes-Gutenberg Universitat, Mainz, Germany), dissolved in Dulbecco's
phosphate-buffered saline (Pierce) at 1 mg/ml, and stored at
80 °C. Immediately before use, SLO was diluted in permeabilization
buffer containing 2 mM dithiothreitol to a final
concentration of 0.25 µg/ml. Vero cells were from the American Tissue
Culture Collection (Manassas, VA). Cell culture media and
antibiotics were from Life Technologies, Inc. All other chemicals and
reagents were of the highest purity available.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-mannosidase II (Fig.
1B), a well established marker of the medial and
trans cisternae of the Golgi (27, 28).

View larger version (17K):
[in a new window]
Fig. 1.
Localization of FITC-VT1B to the Golgi
complex. FITC-VT1B (10 µg/ml) was allowed to bind to the surface
of Vero cells for 1 h at 4 °C. Internalization was induced by
incubation for an additional hour at 37 °C (A). The cells
were then fixed, permeabilized, and labeled with antibody to the Golgi
marker
-mannosidase II, followed by Cy3-conjugated secondary
antibody (B). Bar, 5 µm.

View larger version (56K):
[in a new window]
Fig. 2.
Permeabilization of Vero cells.
A, intact cells stained with 1 µg of FM-143. Note that
only the plasma membrane is labeled. B, cells were
permeabilized using SLO (0.25 µg/ml) for 5 min at 37 °C and then
stained with FM-143 as above. Note extensive labeling of internal
membranes. C, cells were permeabilized with SLO and
pre-equilibrated with 1 mM Lucifer Yellow. Cell-associated
fluorescence was quantified by digital imaging upon removal of
extracellular dye, as described under "Experimental Procedures."
Data are representative of three similar experiments.

View larger version (19K):
[in a new window]
Fig. 3.
Estimation of [K+] using the
null point method. A, FITC-VT1B-labeled cells
were bathed in 140 mM K+ permeabilization
medium, and pHG was measured by ratio imaging. Where
indicated, the plasma membrane was permeabilized by addition of SLO.
After 3 min, the medium was replaced by permeabilization buffer with
the indicated concentration of K+. Finally, 5 µg/ml
nigericin were added where noted. The figure is a composite of three
experiments, each performed at a different [K+]. Data are
the means ± S.E. of four cells from a typical experiment out of
three. B, estimation of the Golgi luminal [K+]
by the null point procedure. The initial rate of pH change induced by
nigericin (in pH/min; ordinate) is plotted versus
the K+ concentration of the bathing medium and cytosol (in
mM; abscissa). Data are the means ± S.E. of three
experiments. The null point is equivalent to the intercept on the
abscissa.
Determinants of Golgi pH
,
'-dipyridyl, 100 µM; TPEN, 20 µM;
GTP
S, 25 µM; amiloride, 100 µM;
N-ethylmaleimide, 100 µM; dicyclohexyl
carbodiimide, 150 µM; ZnCl2, 200 µM. Data are the means of three separate experiments. NA,
not applicable.
To estimate the time required for equilibration of the extracellular solution with the cytosolic compartment following SLO permeabilization, cells were first equilibrated with Lucifer Yellow, and the dye was suddenly removed from the perfusing medium. The rate of fluorescence decay was used as an index of the permeation rate of Lucifer Yellow through the pores generated by SLO. Typical results are illustrated in Fig. 2C. In three similar experiments, the time required for loss of 50% of fluorescence was ~2 s. This value is likely an overestimate of the t1/2 for equilibration of K+ added externally because the molecular size, and therefore the rate of diffusion of Lucifer Yellow differs from that of K+.
We next proceeded to estimate Golgi [K+] by the null
point method (Fig. 3). Cells were bathed in medium containing 140 mM K+, to approximate the cytosolic
[K+]. They were then permeabilized with SLO and perfused
with media of varying [K+] osmotically balanced with
NMG+. 3 min were allowed for equilibration of the cytosolic
compartment with external solution, a time chosen based on the results
of Fig. 2, and nigericin was immediately added. As shown in Fig. 3A, the ionophore induced a rapid alkalinization when added
in medium with 140 mM K+. The alkalosis was
considerably slower at 70 mM K+ and only
marginal at 35 mM. The null point was more precisely calculated by plotting the rate of nigericin-induced change in pHG versus [K+] (Fig.
3B). Using the averages of three experiments, the null point
was attained at ~20 mM [K+]. Because under
the conditions chosen the transmembrane
pH was 0.73, we estimated
the intra-Golgi [K+] to approximate 107 mM,
which is only slightly lower than the cytosolic concentration. This
finding validates the use of nigericin for the in situ
calibration of
pHG.3 Moreover,
it identifies intraluminal K+ as a possible counter-ion to
neutralize the electrogenic action of the V-ATPase.
Are V-ATPases Quiescent at the Resting pHG?
As mentioned in the Introduction, it has been suggested that
organellar pH may be dictated by the level at which the V-ATPase attains thermodynamic equilibrium (25). Alternatively, by analogy with
Na+/H+ exchangers (32, 33), V-ATPases may be
allosterically controlled by H+, reaching quiescence prior
to thermodynamic equilibration. We therefore tested the prediction that
the V-ATPases are quiescent at resting pHG and that they
are unable to pump H+ at more acidic luminal pH. This
analysis required acidification of pHG below its resting
level. We had found earlier that incubation with
NH4+ elicited a rapid alkalosis of the Golgi,
followed by a gradual reacidification that likely reflected accelerated
H+ pumping (11). Subsequent removal of
NH4+ results in a pH "undershoot"
that can be explained by rapid efflux of NH3 (Fig.
4).
|
This paradigm was used to establish the pH dependence of the V-ATPase at and below the resting pHG. To distinguish between passive H+ (equivalent) fluxes and active pumping by the V-ATPase, experiments were performed in the presence and absence of fully inhibitory doses of concanamycin. Typical results are shown in Fig. 4. In the absence of the inhibitor, pHG returned toward the steady state comparatively slowly, requiring upwards of 5 min to re-equilibrate. By contrast, in concanamycin-treated cells pHG reached and exceeded the original baseline much more rapidly. The difference in the rate of realkalinization can be attributed to the V-ATPase. Rates of recovery at varying pHG were calculated in three similar experiments and are summarized in the inset to Fig. 4. It is clear that the rate of alkalosis is greater in the presence of concanamycin at and below the resting pHG, implying that the pump is active under these conditions. We conclude that the resting pHG is not equal to and therefore not dictated by the pH at which the V-ATPase attains quiescence. Other factors must therefore contribute to the establishment of the resting pHG.
Characterization of the Counter-ion Conductance
The observation that the V-ATPase is measurably active at or below the resting pHG implies that its activity is not limited by the permeability to counter-ions. However, earlier reports have implied that pHG is indeed dictated by a limiting counter-ion conductance (34, 35). To resolve this apparent discrepancy, we studied further the role of counter-ions in the establishment of pHG.
Because the preceding findings indicated that intra-Golgi
[K+] is high, we used the conductive ionophore
valinomycin to provide a path for K+ efflux, thereby
increasing the total counter-ion conductance. As summarized in Table I,
addition of 1 µM valinomycin did not decrease
pHG, as would have been expected if counter-ion conductance were rate-limiting. Moreover, addition of the lipid-soluble anion SCN
similarly failed to enhance Golgi acidification
(Table I). It could be argued that little SCN
accumulates
in the cytosol of intact cells, because it is excluded by the plasma
membrane potential. To circumvent this potential problem,
SCN
was also added to cells previously permeabilized with
SLO. As shown in Table I, pHG under these conditions was
similarly unaffected. It is noteworthy that, when added together with
concanamycin, neither valinomycin nor SCN
enhanced the
rate of dissipation of the luminal acidification (Table I). This
indicates that the permeability to H+ (equivalents) was
unaffected by these agents and remained the limiting factor in the
dissipation process.
Another indication of the relative magnitude of the counter-ion
conductance was obtained by comparing the rates of H+
pumping and leakage. Because the pump is active in the steady state,
its tendency to acidify must be balanced by a backward leak of
H+ of equal magnitude. The leak can be easily revealed by
addition of concanamycin (Fig. 5).
Addition of CCCP, an exogenous conductive H+ ionophore to
the cells further increases the rate of dissipation of the pH gradient.
The latter observation implies that the intrinsic H+
conductance was limiting the rate of H+ efflux from the
Golgi, and more importantly, that the counter-ion conductance is
greater than the endogenous H+ conductance. Because at
steady state the rates of the pump and leak are identical, the
counter-ion conductance must also be greater than the rate of pumping
and cannot therefore be rate-limiting.
|
The above experiments rest on the assumption that CCCP selectively increases H+ permeability without affecting the conductance to other ions. This premise was verified in the experiment shown in Fig. 5B. Permeabilized cells were treated with CCCP in medium with 140 mM K+ and pH 7.2, leading to rapid dissipation of the luminal acidification. The concentration of K+ was then rapidly reduced by isoosmotic substitution with NMG+. Despite the large change in the K+ concentration gradient, pHG remained unaltered, indicating that the membrane potential is not significantly altered by this manipulation. This implies that the H+ permeability induced by CCCP is the predominant contributor to the transmembrane conductance and that the ionophore does not appreciably increase K+ permeability under these conditions. Jointly, these observations confirm that, at least in Vero cells, the development of a potential across the Golgi membrane as a result of limited counter-ion permeability cannot explain the observed level of pHG.
Characterization of the H+ Leak
The existence of a large counter-ion conductance and the evidence that the V-ATPase is active in the steady state suggest that pHG is maintained by a dynamic balance between the rates of H+ pumping and leakage. Indeed, the existence of a robust leak was documented above in cells treated with concanamycin (Fig. 5). The remainder of this study was dedicated to the characterization of the leak pathway.
We initially tried to differentiate between physiological transport pathways and imperfections in the continuity of the membrane. The latter would be expected to allow passive diffusion of H+ (equivalents), a process that would have a low temperature coefficient. We therefore tested the temperature dependence of the leak. Reduction of the temperature from 37 to 10 °C immediately before the addition of concanamycin greatly depressed the rate of alkalinization, from 0.16 ± 0.04 to 0.03 ± 0.01 (means ± S.E. of three determinations). This considerable temperature sensitivity suggests that specific transport systems mediate the efflux of H+ from the Golgi complex.
Role of Vesicular Traffic--
Although pHG is acidic,
the luminal pH of the endoplasmic reticulum was shown to be neutral
(10, 11). Because vesicular flux into and out of the Golgi complex is
rapid (36), it was conceivable that delivery of neutral luminal
contents of the endoplasmic reticulum into the Golgi, coupled with loss
of acidic contents from the trans side of the Golgi, would
contribute to the net loss of H+, i.e. to the
leak. This possibility was evaluated by comparing the rates of
H+ leakage under normal conditions and when vesicular
traffic was interrupted. Initial indications were obtained in cells
permeabilized with SLO. Loss of cytosolic components through the large
(10-30 nm) pores generated by SLO would be anticipated to reduce or
eliminate vesicular traffic (37, 38). However, the rate of
H+ leakage, measured as the rate of dissipation of the
acidification upon addition of concanamycin, was not significantly
decreased by washout of cytosolic constituents (Table I). To ascertain that vesicular traffic was impaired, we also permeabilized cells in
medium containing 25 µM GTP
S. This nonhydrolyzable
nucleotide has been reported to prevent uncoating of endoplasmic
reticulum and Golgi-derived vesicles, thereby terminating flow of
membranes and cargo through the Golgi complex. The rate of
concanamycin-induced dissipation of the pH gradient was also unaffected
by the nucleotide (Table I). These observations suggest that vesicular
traffic does not contribute significantly to the efflux of
H+ from the Golgi.
Role of Divalent Metal H+ Transporters--
A system
that co-transports divalent cations with H+ was recently
described to mediate Fe2+ uptake across intestinal and
erythroid cell membranes (39, 40). This transporter, called Nramp2, is
present also in endomembranes (41, 42), where it likely accounts for
the uptake of Fe2+ internalized by transferrin. Nramp1, an
isoform of Nramp2, was also shown to be present in endomembranes (43).
We therefore considered the possibility that an Nramp homolog may exist
in the Golgi, where it could mediate metal-H+ cotransport,
contributing to the H+ leak pathway. The efflux of
H+ from the Golgi was measured as before in cells treated
with two different lipid-soluble heavy metal chelators:
,
'-dipyridyl, which has high affinity for Cu2+ and
Ni2+, and TPEN, which binds Fe2+ and
Cd2+ with high affinity. As summarized in Table I, neither
one of these chelators altered the rate of H+ leakage,
suggesting that Nramp-like metal cotransporters contribute little to
the steady state efflux of H+ from the Golgi.
Role of Na+/H+ Exchange-- Virtually all mammalian cells express Na+/H+ exchangers in their plasma membrane and mitochondrial membranes (44, 45). It is not clear whether Na+/H+ exchangers are also active in the Golgi complex, either as resident transporters or while en route to other organelles following biosynthesis. We explored the possibility that exchange of cytosolic Na+ for luminal H+ accounted for at least part of the Golgi leak pathway. This was accomplished using amiloride, which is a potent inhibitor of several isoforms of the Na+/H+ exchanger family (46). As reported in Table I, amiloride did not affect the resting pH of the Golgi and exerted no inhibition of the leak unmasked by concanamycin.
Because not all members of the Na+/H+ exchanger family are equally sensitive to amiloride, we also analyzed the effect of increasing cytosolic Na+ on the rate of H+ efflux from the Golgi. In cells permeabilized with SLO, a sudden elevation of cytosolic (extracellular) [Na+] from 13 to 103 mM also had little impact on the rate of leakage (Table I). Together with the ineffectiveness of amiloride, these findings argue against a role of Na+/H+ exchangers in the steady state efflux of H+ from the Golgi.
Voltage Dependence of the Leak--
Because bicarbonate was
nominally absent from all the solutions used, it appeared as if neither
Cl
/HCO3
exchange nor
Na+/H+ exchange were responsible for the leak.
As an alternative to electroneutral exchangers, we considered the
involvement of conductive pathways. To this end, the voltage
sensitivity of the rate of leakage was assessed. We compared the rate
of dissipation of
pH under conditions where the potential across the
Golgi membrane was either ~0 mV or highly negative inside. These
conditions were met by permeabilizing the cells with SLO, setting the
cytosolic [K+] to 140 or 0 mM, respectively,
and then making the Golgi membrane preferentially permeable to
K+ by addition of valinomycin. The results of such
experiments are illustrated in Fig. 6.
Addition of concanamycin elicited a faster and greater alkalinization
in medium containing 140 mM K+ than in
K+-free medium. This observation is consistent with a
conductive H+ (equivalent) efflux that would have been
retarded by intraluminal negativity.
|
Insensitivity to Dicyclohexyl Carbodiimide and N-Ethylmaleimide-- Transport of protons through some systems, including the channel moiety of H+-ATPases, can be blocked by dicyclohexyl carbodiimide, a carboxyl group reagent. However, we detected no inhibition of the H+ leak pathway of the Golgi complex in cells treated with 150 µM dicyclohexyl carbodiimide (Table I). Similarly, H+ leakage was not significantly affected by 100 µM of the alkylating agent N-ethylmaleimide. Because they are known to inhibit the V-ATPase, these agents were added immediately before the addition of concanamycin and had only limited time to reach and react with Golgi proteins. We therefore cannot rule out the possibility that these agents may inhibit the leakage pathway(s) if allowed to react more extensively.
Inhibition of the Leak by Zn2+--
A highly
H+-selective conductive pathway has been described in the
membranes of neuronal, epithelial, and myeloid cells (see Refs. 47 and
48 for reviews). Although the molecular entities responsible for the
conductance have not been identified, they share similar
pharmacological properties in all systems tested. Specifically,
permeation of H+ through this pathway is effectively
blocked by Zn2+ and Cd2+ (49). These cations
were used to test the possible involvement of this or a similar pathway
in H+ leakage from the Golgi. To allow access of the
cations to the Golgi membrane, the cells were porated with SLO as
above, and finally, the leak was unmasked by addition of concanamycin.
In the presence of 200 µM Zn2+ the initial
rate of alkalinization was reduced from 0.16 ± 0.04 to 0.04 ± 0.02 pH/min (Fig. 7 and Table I). A
more detailed concentration dependence of the effect of
Zn2+ is shown in Fig. 7B. Notice that a residual
fraction of the leak was not blocked by higher concentrations of
Zn2+, suggesting the existence of multiple components.
|
| |
DISCUSSION |
|---|
|
|
|---|
K+ Concentration inside the Golgi Complex-- To our knowledge, the concentration of free K+ within the Golgi complex had not been determined earlier. Using a null point approach, based on the stoichiometric exchange of K+ for H+ catalyzed by nigericin, we estimated Golgi [K+] to be approximately 107 mM, slightly lower than the concentration of the cytosol. The concentration of the latter is established by the balance between inward pumping of K+ via the Na+/K+ ATPase and the passive leak that occurs primarily via K+ channels, which in turn dictate the membrane potential. The high [K+] of the Golgi can be accounted for by simply assuming that the Golgi membrane possesses a significant permeability to K+ while lacking active K+ transport mechanisms and that the transmembrane potential is almost negligible. The absence of a measurable potential is consistent with the effects of ionophores and lipid-soluble anions on pH (see below).
The high intra-Golgi [K+], together with the presence of K+ permeation pathways, suggest that efflux of this cation could serve to neutralize the inward pumping of H+ by the V-ATPase. The physiological significance of the high intra-Golgi K+ is otherwise not clear, but it is conceivable that, as described for some cytosolic pathways (50), some of the enzymes within the Golgi perform optimally at high concentrations of this cation.
Role of Membrane Potential as a Determinant of
pHG--
In vitro determinations using isolated
Golgi fractions had shown earlier that increasing counter-ion
conductance by means of ionophores enhanced luminal acidification
(51). Moreover, Llopis et al. (13) showed more
recently that removal of extracellular Cl
, which
presumably was accompanied by depletion of cytosolic Cl
,
rapidly dissipated the acidification of the Golgi lumen. These observations indicate that the rate of pumping by the electrogenic V-ATPase can be limited by the generation of a transmembrane voltage. In fact, such a limitation has been repeatedly hypothesized to be the
primary determinant of intraorganellar pH (25, 34).
In the case of the Golgi, however, several findings in this and other
reports argue convincingly against this possibility. First, flux of
counter-ions through the endogenous conductance was shown to be greater
than the rate of H+ pumping at the steady state. This was
concluded from the ability of the conductance to support a rapid
dissipation of
pH upon addition of a conductive protonophore (Fig.
5). In these experiments, the rate of dissipation was greater than that
observed upon addition of concanamycin, which was used as a measure of
the rate of pumping (see "Results"). Secondly, pHG
failed to become more acidic when putatively membrane-permeant anions
were present or when valinomycin was added. As discussed above, the
substrate transported by this conductive ionophore, namely
K+, was plentiful within the Golgi. The inability of
valinomycin to alter pHG, which had been noted earlier by
Llopis et al. (13), also implies that the electrical
potential across the Golgi membrane is insignificant. To the extent
that the V-ATPase is electrogenic, any modification in the prevailing
voltage would be anticipated to alter the rate of pumping. Because
valinomycin is expected to clamp the potential near zero, given the
similarity of the cytosolic and intra-Golgi [K+], the
constancy of pHG suggests that the resting voltage is
negligible. Thirdly, while this manuscript was in preparation, Farinas
and Verkman (19) reported that the V-ATPase is not quiescent at the
steady state pHG. The results in our Fig. 4 are consistent with this interpretation, demonstrating the presence of
bafilomycin-sensitive changes in pHG below the resting
level. The cumulative evidence suggests that counter-ion conductance is
not rate-limiting to H+ pumping, at least near the steady
state pH, and therefore that membrane potential is not an important
determinant of pHG.
Allosteric Control of the V-ATPase-- Other transporters, like the family of Na+/H+ antiporters, attain near-quiescence despite the persistence of large thermodynamic. The reduced activity has been attributed to an allosteric site that upon protonation exerts an inhibitory effect on the exchangers gradients (33). Conceivably, a similar effect could contribute to the establishment of the pH set point of the Golgi. However, both our results and those of Farinas and Verkman (19) revealed an approximately linear relationship between pHG and the rate of H+ pumping in the range studied. This contrasts with the sharp decline in Na+/H+ exchanger activity as the cytosolic pH approaches the steady state. Thus, although the occurrence of allosteric control of the V-ATPase has not been ruled out, it does not appear to be the primary determinant of the steady state pHG.
Contribution and Nature of H+ Leak Pathways-- The existence of a sizable H+ (equivalent) backflux or leak when pHG is at equilibrium can be readily revealed by inhibition of the pump (Fig. 5 and Refs. 11, 13, and 19). Because by definition the magnitude of this leak must equal the rate of pumping at the steady state, passive H+ backflux is an essential contributor to the establishment of pHG. Indeed, it is likely that the differential luminal pH of organelles within the endocytic and secretory pathways is dictated as much by the magnitude of their leak as by the density and activity of their pumps.
Despite the importance of the passive H+ conduction pathways, little is known about their nature. Several insights were provided by the results in Figs. 5-7 and in Table I. Briefly, the net loss of H+ is not likely a consequence of import of alkaline solution from the endoplasmic reticulum via vesicular traffic nor of delivery of acidic vesicles toward the trans-Golgi network. Similarly, we found no evidence that either Na+/H+ exchange or Nramp-related molecules transport H+ out of the Golgi. Bicarbonate transport via an anion exchanger is also deemed unlikely, because all our measurements were carried out in nominally bicarbonate-free medium. Instead, at least part of the flux occurs via a conductive pathway, inasmuch as it is altered by manipulation of the electrical potential across the Golgi membrane (Fig. 6). Like the H+-selective conductance found in the plasma membrane of several cell types (47, 48), the backflux of H+ from the Golgi was inhibited by micromolar concentrations of Zn2+. Therefore, the pathways involved may bear some similarity. The plasmalemmal system displays very small unitary conductance (48), arguing against a continuous large pore across the membrane. The alternative possibilities, involving intimate association of the ions with the channel or a carrier mechanism that requires conformational changes, are consistent with the large temperature coefficient of the leak pathway of the Golgi. Direct electrophysiological analysis will be required to more thoroughly characterize the Golgi leak pathway.
In summary, we propose that pHG is dictated by a compromise
between the rates of H+ pumping and leakage. If
pHG is indeed established by the balance between pump and
leak, blockade of the latter would be predicted to accentuate the
luminal acidification. Unfortunately, this premise cannot be tested at
present because Zn2+, the only identified inhibitor of the
leak, is also a powerful inhibitor of the V-ATPase (52, 53). Finally,
although the H+ backflux pathway(s) include a
Zn2+-sensitive conductive system, the contribution of
substrate-H+ symporters or antiporters has not been
excluded. Such systems could take advantage of the transmembrane pH
gradient to accumulate substrates or eliminate metabolic products from
the Golgi. Clearly, the rate of the V-ATPase and the magnitude of the
leakage need not be invariant, and modulation of one or both of these
systems could result in alteration of pHG. A better
understanding of the regulation of the pump and leak is therefore essential.
| |
FOOTNOTES |
|---|
* This work was supported by the Canadian Cystic Fibrosis Foundation and the Medical Research Council of Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
International Scholar of the Howard Hughes Medical Institute.
Recipient of a Medical Research Council Distinguished Scientist Award.
Current holder of the Pitblado Chair in Cell Biology. To whom
correspondence should be addressed: Cell Biology Programme, Hospital
for Sick Children, 555 University Ave., Toronto, ON M5G 1X8, Canada.
Tel.: 416-813-5727; Fax: 416-813-5028; E-mail:
sga@sickkids.on.ca.
Published, JBC Papers in Press, March 27, 2000, DOI 10.1074/jbc.M002386200
2 Calculated using a stoichiometry of 3 and 50 kJ/mol as the free energy of ATP hydrolysis by the V-ATPase (54). A minimum pH of 4.4 is calculated using a stoichiometry of 2.
3 The error in the pHG calculations introduced by the difference between the extracellular [K+] and the intra-Golgi [K+] would be 0.11 units.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
V-ATPase, vacuolar-type ATP hydrolase;
FITC, fluorescein isothiocyanate;
NMG+, N-methyl-D-glucammonium;
pHG, Golgi pH;
SLO, streptolysin O;
TPEN, N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine;
VT1B, recombinant B subunit of verotoxin 1;
GTP
S, guanosine
5'-3-O-(thio)triphosphate;
MES, 4-morpholineethanesulfonic
acid;
CCCP, carbonyl cyanide p-chlorophenylhydrazone.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Saraste, M (1999) Science 283, 1488-1493 |
| 2. | Mellman, I., Fuchs, R., and Helenius, A. (1986) Annu. Rev. Biochem. 55, 663-700 |
| 3. | Davoust, J., Gruenberg, J., and Howell, K. E. (1987) EMBO J. 6, 3601-3609 |
| 4. | van Weert, A. W., Dunn, K. W., Geuze, H. J., Maxfield, F. R., and Stoorvogel, W. (1995) J. Cell Biol. 130, 821-834 |
| 5. | Chanat, E., and Huttner, W. B. (1991) J. Cell Biol. 115, 1505-1519 |
| 6. | Mellman, I. (1992) J. Exp. Biol. 172, 39-45 |
| 7. | Xu, H., and Shields, D. (1994) J. Biol. Chem. 269, 22875-22881 |
| 8. | Maxfield, F. R., and Yamashiro, D. J. (1991) Intracellular Trafficking of Proteins , pp. 157-182, Cambridge University Press, Cambridge, UK |
| 9. | Kim, J. H., Johannes, L., Goud, B., Antony, C., Lingwood, C. A., Daneman, R., and Grinstein, S. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 2997-3002 |
| 10. | Kneen, M., Farinas, J., Li, Y., and Verkman, A. S. (1998) Biophys. J. 74, 1591-1599 |
| 11. | Demaurex, N., Furuya, W., D'Souza, S., Bonifacino, J. S., and Grinstein, S. (1998) J. Biol. Chem. 273, 2044-2051 |
| 12. | Kim, J. H., Lingwood, C. A., Williams, D. B., Furuya, W., Manolson, M. F., and Grinstein, S. (1996) J. Cell Biol. 134, 1387-1399 |
| 13. | Llopis, J., McCaffery, J. M., Miyawaki, A., Farquhar, M. G., and Tsien, R. Y. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6803-6808 |
| 14. | Seksek, O., Biwersi, J., and Verkman, A. S. (1996) J. Biol. Chem. 271, 15542-15548 |
| 15. | Chapman, R. E., and Munro, S. (1994) EMBO J. 13, 2305-2312 |
| 16. | Anderson, R. G., and Pathak, R. K. (1985) Cell 40, 635-643 |
| 17. | Orci, L., Ravazzola, M., and Anderson, R. G. (1987) Nature 326, 77-79 |
| 18. | Seksek, O., Biwersi, J., and Verkman, A. S. (1995) J. Biol. Chem. 270, 4967-4970 |
| 19. | Farinas, J., and Verkman, A. S. (1999) J. Biol. Chem. 274, 7603-7606 |
| 20. | Johannes, L., and Goud, B. (1998) Trends Cell Biol. 8, 158-162 |
| 21. | Sandvig, K., Garred, O., Prydz, K., Kozlov, J. V., Hansen, S. H., and van Deurs, B. (1992) Nature 358, 510-512 |
| 22. | Al-Awqati, Q. (1986) Annu. Rev. Cell Biol. 2, 179-199 |
| 23. | Roos, A., and Boron, W. F. (1981) Physiol. Rev. 61, 296-434 |
| 24. | Eisner, D. A., Kenning, N. A., O'Neill, S. C., Pocock, G., Richards, C. D., and Valdeolmillos, M. (1989) Pfleugers Arch. Eur J. Physiol. 413, 553-558 |
| 25. | Rybak, S. L., Lanni, F., and Murphy, R. F. (1997) Biophys. J. 73, 674-687 |
| 26. | Boulanger, J., Huesca, M., Arab, S., and Lingwood, C. A. (1994) Anal. Biochem. 217, 1-6 |
| 27. | Novikoff, P. M., Tulsiani, D. R., Touster, O., Yam, A., and Novikoff, A. B. (1983) Proc. Natl. Acad. Sci. U. S. A. 80, 4364-4368 |
| 28. | Rabouille, C., Hui, N., Hunte, F., Kieckbusch, R., Berger, E. G., Warren, G., and Nilsson, T. (1995) J. Cell Sci. 108, 1617-1627 |
| 29. | Babcock, D. F. (1983) J. Biol. Chem. 258, 6380-6389 |
| 30. | Markin, V. S., Sokolov, V. S., Bogulavsky, L. I., and Jaguzhinsky, L. S. (1975) J. Membr. Biol. 25, 23-45 |
| 31. | Bhakdi, S., Weller, U., Walev, I., Martin, E., Jonas, D., and Palmer, M. (1993) Med. Microbiol. Immunol. 182, 167-175 |
| 32. | Aronson, P. S., Nee, J., and Suhm, M. A. (1982) Nature 299, 161-163 |
| 33. | Kinsella, J. L., Heller, P., and Froehlich, J. P. (1998) Biochem. Cell Biol. 76, 743-749 |
| 34. | Barasch, J., Kiss, B., Prince, A., Saiman, L., Gruenert, D., and al-Awqati, Q. (1991) Nature 352, 70-73 |
| 35. | Al-Awqati, Q., Barasch, J., and Landry, D. (1992) J. Exp. Biol. 172, 245-266 |
| 36. | Hirschberg, K., Miller, C. M., Ellenberg, J., Presley, J. F., Siggia, E. D., Phair, R. D., and Lippincott-Schwartz, J. (1998) J. Cell Biol. 143, 1485-1503 |
| 37. | Melancon, P., Glick, B. S., Malhotra, V., Weidman, P. J., Serafini, T., Gleason, M. L., Orci, L., and Rothman, J. E. (1987) Cell 51, 1053-1062 |
| 38. | Nichols, B. J., and Pelham, H. R. (1998) Biochim. Biophys. Acta 1404, 9-31 |
| 39. | Fleming, M. D., Trenor, C. C., 3rd, Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., and Andrews, N. C. (1997) Nat. Genet. 16, 383-386 |
| 40. | Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., and Hediger, M. A. (1997) Nature 388, 482-488 |
| 41. | Fleming, M. D., Romano, M. A., Su, M. A., Garrick, L. M., Garrick, M. D., and Andrews, N. C. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 1148-1153 |
| 42. | Gruenheid, S., Canonne-Hergaux, F., Gauthier, S., Hackam, D. J., Grinstein, S., and Gros, P. (1999) J. Exp. Med. 189, 831-841 |
| 43. | Gruenheid, S., Pinner, E., Desjardins, M., and Gros, P. (1997) J. Exp. Med. 185, 717-730 |
| 44. | Orlowski, J., and Grinstein, S. (1997) J. Biol. Chem. 272, 22373-22376 |
| 45. | Numata, M., Petrecca, K., Lake, N., and Orlowski, J. (1998) J. Biol. Chem. 273, 6951-6959 |
| 46. | Harris, C., and Fliegel, L. (1999) Int. J. Mol. Med. 3, 315-321 |
| 47. | Lukacs, G. L., Kapus, A., Nanda, A., Romanek, R., and Grinstein, S. (1993) Am. J. Physiol. 265, C3-C14 |
| 48. | DeCoursey, T. E. (1998) Frontiers Biosci. 1, 477-482 |
| 49. | Mahaut-Smith, M. P. (1989) J. Exp. Biol. 145, 455-464 |
| 50. | Robinson, J. D., Levine, G. M., and Robinson, L. J. (1983) Biochim. Biophys. Acta 731, 406-414 |
| 51. | Glickman, J., Croen, K., Kelly, S., and Al-Awqati, Q (1983) J. Cell Biol. 97, 1303-1308 |
| 52. | Yamashiro, D. J., Fluss, S. R., and Maxfield, F. R. (1983) J. Cell Biol. 97, 929-934 |
| 53. | Sabolic, I., and Burckhardt, G. (1986) Am. J. Physiol. 250, F817-F826 |
| 54. | Dixon, T. E., and Al-Awqati, Q. (1980) J. Biol. Chem. 255, 3237-3239 |
This article has been cited by other articles:
![]() |
M. Fukuda, M. Nakano, M. Miyazaki, M. Tanaka, H. Saito, S. Kobayashi, M. Ueno, and T. Handa Conformational change of apolipoprotein A-I and HDL formation from model membranes under intracellular acidic conditions J. Lipid Res., November 1, 2008; 49(11): 2419 - 2426. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Ahmed and B. Pelster Ionic determinants of pH of acidic compartments under hypertonic conditions in trout hepatocytes J. Exp. Biol., October 15, 2008; 211(20): 3306 - 3314. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Lehane, R. Hayward, K. J. Saliba, and K. Kirk A verapamil-sensitive chloroquine-associated H+ leak from the digestive vacuole in chloroquine-resistant malaria parasites J. Cell Sci., May 15, 2008; 121(10): 1624 - 1632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Eswarappa, N. Basu, O. Joy, and D. Chakravortty Folimycin (concanamycin A) inhibits LPS-induced nitric oxide production and reduces surface localization of TLR4 in murine macrophages Innate Immunity, February 1, 2008; 14(1): 13 - 24. [Abstract] [PDF] |
||||
![]() |
K. K. Huynh and S. Grinstein Regulation of Vacuolar pH and Its Modulation by Some Microbial Species Microbiol. Mol. Biol. Rev., September 1, 2007; 71(3): 452 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Machen Innate immune response in CF airway epithelia: hyperinflammatory? Am J Physiol Cell Physiol, August 1, 2006; 291(2): C218 - C230. [Abstract] [Full Text] [PDF] |
||||